296 related articles for article (PubMed ID: 20889945)
21. Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands.
Holleboom CA; van Eyck J; Koenen SV; Kreuwel IA; Bergwerff F; Creutzberg EC; Bruinse HW
Arch Gynecol Obstet; 2013 Jun; 287(6):1111-7. PubMed ID: 23329341
[TBL] [Abstract][Full Text] [Related]
22. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
Chaudhuri P; Banerjee GB; Mandal A
Int J Gynaecol Obstet; 2010 Apr; 109(1):25-9. PubMed ID: 20070961
[TBL] [Abstract][Full Text] [Related]
23. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial.
Davies GA; Tessier JL; Woodman MC; Lipson A; Hahn PM
Obstet Gynecol; 2005 Feb; 105(2):294-9. PubMed ID: 15684155
[TBL] [Abstract][Full Text] [Related]
24. [Oxytocin for the prophylaxis of uterine atony after cesarean delivery. Should we reconsider our protocols?].
Schiraldi R; Guasch E
Rev Esp Anestesiol Reanim; 2014; 61(7):359-61. PubMed ID: 24924341
[No Abstract] [Full Text] [Related]
25. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
Owonikoko KM; Arowojolu AO; Okunlola MA
J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
[TBL] [Abstract][Full Text] [Related]
26. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose.
Cordovani D; Balki M; Farine D; Seaward G; Carvalho JC
Can J Anaesth; 2012 Aug; 59(8):751-7. PubMed ID: 22717890
[TBL] [Abstract][Full Text] [Related]
27. Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest.
Balki M; Dhumne S; Kasodekar S; Kingdom J; Windrim R; Carvalho JC
BJOG; 2008 Apr; 115(5):579-84. PubMed ID: 18333937
[TBL] [Abstract][Full Text] [Related]
28. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
[TBL] [Abstract][Full Text] [Related]
29. A Randomized, Double-blinded Trial of a "Rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery.
Kovacheva VP; Soens MA; Tsen LC
Anesthesiology; 2015 Jul; 123(1):92-100. PubMed ID: 25909969
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.
Badejoko OO; Ijarotimi AO; Awowole IO; Loto OM; Badejoko BO; Olaiya DS; Fatusi AO; Kuti O; Orji EO; Ogunniyi SO
J Obstet Gynaecol Res; 2012 Nov; 38(11):1294-301. PubMed ID: 22612662
[TBL] [Abstract][Full Text] [Related]
31. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial.
Sheehan SR; Montgomery AA; Carey M; McAuliffe FM; Eogan M; Gleeson R; Geary M; Murphy DJ;
BMJ; 2011 Aug; 343():d4661. PubMed ID: 21807773
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery.
Wetta LA; Szychowski JM; Seals S; Mancuso MS; Biggio JR; Tita AT
Am J Obstet Gynecol; 2013 Jul; 209(1):51.e1-6. PubMed ID: 23507549
[TBL] [Abstract][Full Text] [Related]
33. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage.
Jackson KW; Allbert JR; Schemmer GK; Elliot M; Humphrey A; Taylor J
Am J Obstet Gynecol; 2001 Oct; 185(4):873-7. PubMed ID: 11641669
[TBL] [Abstract][Full Text] [Related]
34. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section.
Dansereau J; Joshi AK; Helewa ME; Doran TA; Lange IR; Luther ER; Farine D; Schulz ML; Horbay GL; Griffin P; Wassenaar W
Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 1):670-6. PubMed ID: 10076146
[TBL] [Abstract][Full Text] [Related]
35. Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.
Bischoff K; Nothacker M; Lehane C; Lang B; Meerpohl J; Schmucker C
BMC Pregnancy Childbirth; 2017 Nov; 17(1):399. PubMed ID: 29187156
[TBL] [Abstract][Full Text] [Related]
36. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study.
Hamm J; Russell Z; Botha T; Carlan SJ; Richichi K
Am J Obstet Gynecol; 2005 May; 192(5):1404-6. PubMed ID: 15902121
[TBL] [Abstract][Full Text] [Related]
37. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
Vimala N; Mittal S; Kumar S
Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
[TBL] [Abstract][Full Text] [Related]
38. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery--a double-blind randomised controlled trial.
Su LL; Rauff M; Chan YH; Mohamad Suphan N; Lau TP; Biswas A; Chong YS
BJOG; 2009 Oct; 116(11):1461-6. PubMed ID: 19538418
[TBL] [Abstract][Full Text] [Related]
39. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
[TBL] [Abstract][Full Text] [Related]
40. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
Chaudhuri P; Mandi S; Mazumdar A
J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
